Comparing immunogenicity and efficacy of two different mRNA-based COVID-19 vaccines as a fourth dose; six-month follow-up, Israel, 27 December 2021 to 24 July 2022

por Barda, Noam, Canetti, Michal, Gilboa, Mayan, Indenboim, Victoria, Asraf, Keren, Weiss-Ottolenghi, Yael, Amit, Sharon, Zibly, Daniel, Doolman, Ram, Mendelson, Ella, Harats, Dror, Freedman, Laurence S., Kreiss, Yitshak, Lustig, Yaniv, Regev-Yochay, Gili
Publicado 2022

Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up

por Barda, Noam, Lustig, Yaniv, Indenbaum, Victoria, Zibly, Daniel, Joseph, Gili, Asraf, Keren, Weiss-Ottolenghi, Yael, Amit, Sharon, Kliker, Limor, Abd Elkader, Bayan, Ben-Ami, Eytan, Canetti, Michal, Koren, Ravit, Katz-Likvornik, Shiri, Halpern, Osnat, Mendelson, Ella, Doolman, Ram, Harats, Dror, Kreiss, Yitshak, Mandelboim, Michal, Regev-Yochay, Gili
Publicado 2023